Tech Company Financing Transactions

Glaukos Funding Round

Glaukos closed a $30 million Series F funding round on 2/8/2013. Backers included Meritech Capital Partners, Domain Associates and Frazier Healthcare Partners.

Transaction Overview

Company Name
Glaukos
Announced On
2/8/2013
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series F
Investors

Meritech Capital Partners (Lead Investor) (Paul Madera)

Domain Associates

Frazier Healthcare Partners (Robert More)

Gund Investment Corporation

InterWest Partners (Gil Kliman)

Montreux Equity Partners (John Savarese)

OrbiMed

Versant Ventures (William Link)

Proceeds Purpose
The funds also will be used for investigational device exemption pivotal registration studies of iStent supra, a suprachoroidal implant, and iStent inject, a second-generation trabecular bypass implant.

Company Information

Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
229 Avenida Fabricante
San Clemente, CA 92672
USA
Phone
(949) 481-0510
Website
www.glaukos.com
Email Address
[email protected]
Overview
Transforming Open-Angle Glaucoma Management Founded in 2001 and headquartered in Orange County, California, Glaukos Corporation is an ophthalmic medical device company that is committed to transforming the management of open-angle glaucoma.
Profile
Glaukos LinkedIn Company Profile
Social Media
Glaukos Company Twitter Account
Company News
Glaukos News
Facebook
Glaukos on Facebook
YouTube
Glaukos on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Thomas Burns
  Thomas Burns LinkedIn Profile  Thomas Burns Twitter Account  Thomas Burns News  Thomas Burns on Facebook
Chief Financial Officer
Joseph Gilliam
  Joseph Gilliam LinkedIn Profile  Joseph Gilliam Twitter Account  Joseph Gilliam News  Joseph Gilliam on Facebook
Chief Medical Officer
Jay Katz
  Jay Katz LinkedIn Profile  Jay Katz Twitter Account  Jay Katz News  Jay Katz on Facebook
Chief Operating Officer
Chris Calcaterra
  Chris Calcaterra LinkedIn Profile  Chris Calcaterra Twitter Account  Chris Calcaterra News  Chris Calcaterra on Facebook
Vice President
David Haffner
  David Haffner LinkedIn Profile  David Haffner Twitter Account  David Haffner News  David Haffner on Facebook
VP - General Counsel
Robert Davis
  Robert Davis LinkedIn Profile  Robert Davis Twitter Account  Robert Davis News  Robert Davis on Facebook
VP - Human Resources
Michele Allegretto
  Michele Allegretto LinkedIn Profile  Michele Allegretto Twitter Account  Michele Allegretto News  Michele Allegretto on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/8/2013: Proton Digital Systems venture capital transaction
Next: 2/8/2013: PharmaJet venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.